Zobrazeno 1 - 10
of 22
pro vyhledávání: '"Chang-Ru Wu"'
Publikováno v:
International Journal of Molecular Sciences, Vol 25, Iss 1, p 433 (2023)
Hepatocellular carcinoma (HCC) usually recurs after curative surgical resection. Currently, no approved adjuvant therapy has been shown to reduce HCC recurrence rates. In this study, the in vivo effect of sequential combination treatment with recombi
Externí odkaz:
https://doaj.org/article/835a14717f8741948f627b7bdaa154ec
Autor:
Jau-Hau Horng, Wei-Hsiang Lin, Chang-Ru Wu, You-Yu Lin, Li-Ling Wu, Ding-Shinn Chen, Pei-Jer Chen
Publikováno v:
Journal of Biomedical Science, Vol 27, Iss 1, Pp 1-16 (2020)
Abstract Background Hepatitis B virus (HBV) persistently infected about 250 million people worldwide, and a curative treatment remains an unmet medical need. Among many approaches to treat chronic hepatitis B (CHB), therapeutic vaccines have been dev
Externí odkaz:
https://doaj.org/article/bc5ae5955993494189e8813b095bacfe
Autor:
Chang-Ru Wu, 吳昌儒
100
A hub in a network is a node with high transfer rate and building cost. The hub location problem is to find how many and where to build the hubs such that we can obtain the best benefit in the network. By considering only the location issue,
A hub in a network is a node with high transfer rate and building cost. The hub location problem is to find how many and where to build the hubs such that we can obtain the best benefit in the network. By considering only the location issue,
Externí odkaz:
http://ndltd.ncl.edu.tw/handle/66966b
Autor:
Chang-Ru Wu, 吳昶儒
96
In the economics and strategy fields, understanding the sources of performance differences is a key theoretical and empirical issue. It has long been conventional to treat the firm as a basic unit of analysis when considering the performance
In the economics and strategy fields, understanding the sources of performance differences is a key theoretical and empirical issue. It has long been conventional to treat the firm as a basic unit of analysis when considering the performance
Externí odkaz:
http://ndltd.ncl.edu.tw/handle/85023644704287175896
Autor:
Chang‐Ru Wu, Hyun‐Jin Kim, Cheng‐Pu Sun, Chen‐Yen Chung, You‐Yu Lin, Mi‐Hua Tao, Jung‐Hwan Kim, Ding‐Shinn Chen, Pei‐Jer Chen
Publikováno v:
Hepatology (Baltimore, Md.)REFERENCES. 76(1)
Hepatitis B immunoglobulin (HBIG) has been routinely applied in the liver transplantation setting to block HBV reinfection of grafts. However, new monoclonal anti-HBV surface antibodies have been developed to replace HBIG. The epitopes of such monocl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c149425f1a8707562ec3f17e82586d57
https://pubmed.ncbi.nlm.nih.gov/34957587
https://pubmed.ncbi.nlm.nih.gov/34957587
Autor:
Wei Hsiang Lin, Jau Hau Horng, Ding-Shinn Chen, Li Ling Wu, Chang Ru Wu, You Yu Lin, Pei-Jer Chen
Publikováno v:
Journal of Biomedical Science
Journal of Biomedical Science, Vol 27, Iss 1, Pp 1-16 (2020)
Journal of Biomedical Science, Vol 27, Iss 1, Pp 1-16 (2020)
Background Hepatitis B virus (HBV) persistently infected about 250 million people worldwide, and a curative treatment remains an unmet medical need. Among many approaches to treat chronic hepatitis B (CHB), therapeutic vaccines have been developed fo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3959ef55dd48b449829a3494ac67918c
http://europepmc.org/articles/PMC7257178
http://europepmc.org/articles/PMC7257178
Autor:
Jau-Hau Horng, Wei-Hsiang Lin, Chang-Ru Wu, Lin, You-Yu, Wu, Li-Ling, Ding-Shinn Chen, Chen, Pei-Jer
Additional file 1: Figure S1. Structures of RAP1-HBx, RAP1-E7 and pEt32a-HBx; Figure S2. HBV carrier mice do not produce protective anti-HBs antibodies; Figure S3. HBx vaccine immunization removes serum HBs in mice carrying different HBV genotypes; F
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3a15cac1cb9cd837053afbedcde353f4
Autor:
Jun-Fang Zhang, Tong Cheng, James Wk Shih, Xiaobing Mo, Chang-Ru Wu, Cheng-Pu Sun, Guo Xueran, Tianying Zhang, Yali Zhang, Ying Zhang, Quan Yuan, Y. Adam Yuan, Jing-Hua Zhao, Jun Zhang, Mi-Hua Tao, Yu-Chieh Lo, Ningshao Xia, Yixin Chen, Wenxin Luo, Jiali Cao, Ying Lan, Pei-Jer Chen, Xuan Liu, Qinjian Zhao, Lunzhi Yuan
Publikováno v:
Gut. 65:658-671
Objective This study aimed to investigate the therapeutic potential of monoclonal antibody (mAb) against HBV as a novel treatment approach to chronic hepatitis B (CHB) in mouse models. Methods Therapeutic effects of mAbs against various epitopes on v
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1b383d920267451befacef7e1df4d4a4
https://doi.org/10.1136/gutjnl-2014-308964
https://doi.org/10.1136/gutjnl-2014-308964
Publikováno v:
Hepatitis B Virus and Liver Disease ISBN: 9789811048425
Chronic hepatitis B is a global health issue, as WHO estimates about 240 millions in the world. Without antiviral therapies, a quarter of the HBV carriers will eventually succumb to cirrhosis or hepatocellular carcinoma (Fattovich et al. 2004; Di Bis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::857f316b9bfb6d45a04b50944ef8b90b
https://doi.org/10.1007/978-981-10-4843-2_17
https://doi.org/10.1007/978-981-10-4843-2_17
Autor:
Ko Jiunn Liu, Ming Fang Tsai, Nei Min Chu, An Chen Feng, Li-Han Hsu, Chang Ru Wu, Shu Huei Kao
Publikováno v:
Cancer Science
Estrogen has been postulated to contribute to the development and progression of lung cancer. We examined the epidemiologic evidence, explored the characteristics of estrogen receptors (ER) in lung adenocarcinoma, and investigated the effect of estro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4e00dc6a299d17ac469cc567efd834d8
https://doi.org/10.1111/cas.12558
https://doi.org/10.1111/cas.12558